Free Trial

Concentrix (NASDAQ:CNXC) Stock Price Down 6.2% - What's Next?

Concentrix logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Concentrix shares were down 6.2%, trading as low as $38.93 and last around $39.03 on about 233,488 shares (≈79% below average), and sit below their 50‑day ($39.87) and well under the 200‑day ($45.62) moving averages.
  • The company slightly beat quarterly estimates (EPS $2.95 vs. $2.93; revenue $2.55B vs. $2.54B) but reported a negative net margin (-13.02%); management issued FY 2026 guidance of 11.48–12.07 EPS
  • Concentrix declared a $0.36 quarterly dividend (4.0% yield) despite a negative payout ratio, analysts are mixed with an average rating of "Moderate Buy" and a ~$63.75 target, and institutional investors hold roughly 90% of the stock.
  • Interested in Concentrix? Here are five stocks we like better.

Concentrix Corporation (NASDAQ:CNXC - Get Free Report) was down 6.2% on Wednesday . The stock traded as low as $38.93 and last traded at $39.0280. Approximately 233,488 shares traded hands during mid-day trading, a decline of 79% from the average daily volume of 1,127,027 shares. The stock had previously closed at $41.61.

Analyst Upgrades and Downgrades

CNXC has been the subject of a number of recent analyst reports. Wall Street Zen cut shares of Concentrix from a "buy" rating to a "hold" rating in a research note on Saturday, January 17th. Weiss Ratings raised Concentrix from a "sell (d+)" rating to a "hold (c-)" rating in a report on Thursday, January 8th. Barrington Research reiterated an "outperform" rating and issued a $62.00 price objective on shares of Concentrix in a research note on Monday, January 12th. Finally, Robert W. Baird set a $52.00 price objective on Concentrix in a report on Wednesday, January 14th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $63.75.

Get Our Latest Research Report on Concentrix

Concentrix Stock Performance

The stock has a market cap of $2.26 billion, a price-to-earnings ratio of -1.74, a P/E/G ratio of 0.45 and a beta of 0.48. The company has a quick ratio of 1.56, a current ratio of 1.40 and a debt-to-equity ratio of 1.67. The company has a 50 day simple moving average of $39.87 and a 200 day simple moving average of $45.62.

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.93 by $0.02. The company had revenue of $2.55 billion for the quarter, compared to analyst estimates of $2.54 billion. Concentrix had a negative net margin of 13.02% and a positive return on equity of 16.91%. The firm's revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the firm posted $3.26 EPS. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. As a group, equities research analysts forecast that Concentrix Corporation will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 10th. Investors of record on Friday, January 30th will be given a dividend of $0.36 per share. The ex-dividend date is Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a yield of 4.0%. Concentrix's payout ratio is currently -6.91%.

Insider Transactions at Concentrix

In other news, CEO Christopher A. Caldwell bought 2,000 shares of the company's stock in a transaction on Thursday, October 30th. The stock was purchased at an average cost of $42.03 per share, for a total transaction of $84,060.00. Following the completion of the transaction, the chief executive officer owned 286,661 shares of the company's stock, valued at $12,048,361.83. This trade represents a 0.70% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 3.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC grew its holdings in Concentrix by 1.8% during the 3rd quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company's stock worth $202,175,000 after acquiring an additional 75,352 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of Concentrix by 18.4% during the third quarter. Dimensional Fund Advisors LP now owns 1,939,492 shares of the company's stock worth $89,515,000 after purchasing an additional 301,550 shares during the period. State Street Corp grew its stake in shares of Concentrix by 8.7% in the second quarter. State Street Corp now owns 1,622,854 shares of the company's stock worth $85,776,000 after purchasing an additional 130,529 shares during the last quarter. 1832 Asset Management L.P. increased its holdings in Concentrix by 3.1% in the second quarter. 1832 Asset Management L.P. now owns 1,544,997 shares of the company's stock valued at $81,661,000 after purchasing an additional 46,856 shares during the period. Finally, Invenomic Capital Management LP raised its position in Concentrix by 19.7% during the 3rd quarter. Invenomic Capital Management LP now owns 822,345 shares of the company's stock worth $37,951,000 after purchasing an additional 135,429 shares during the last quarter. Institutional investors own 90.34% of the company's stock.

About Concentrix

(Get Free Report)

Concentrix Inc NASDAQ: CNXC is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines